Naproxen
Product Images NDC 52959-516

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 52959-516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Naproxen Structural Formula (Fac2516e 4667 4558 B704 7811463da260 01)

Naproxen Structural Formula (Fac2516e 4667 4558 B704 7811463da260 01)
Chemical structure diagram of the active ingredient Naproxen, showing the molecular arrangement and functional groups consistent with its chemical formula.*
FDA Label Image

Naproxen Delayed-release Tablets Usp 500 mg 100s Label (Fac2516e 4667 4558 B704 7811463da260 03)

Naproxen Delayed-release Tablets Usp 500 mg 100s Label (Fac2516e 4667 4558 B704 7811463da260 03)
Label for Naproxen 500 mg delayed-release tablets by H.J. Harkins Company, Inc., showing product NDC 52959-516-30. The label includes lot number NPE550TV, manufacturer Teva Pharm from Israel, expiration 06/09, and describes the tablets as white capsule-shaped. Contains dosage instruction to take as directed by a doctor. Also shows multiple small identical labels with similar information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.